Full Dev Support for Genomic Cancer Care

Full Dev Support for Genomic Cancer Care

Client

Industry

Capabilities

Technology

Last Updated

Since releasing their first cancer test to the market in 2012, Foundation Medicine has partnered with unosquare to transform cancer care with 5 different cancer tests and millions of reports delivered to physicians and patients.

Foundation Medicine produces in depth reporting on genomic mutations and recommended therapies individual to each patient.

unosquare has provided development support in every technical aspect from laboratory tools to customer billing platforms.

Team
  • 1 Business Analyst / Scrum Master
  • 13 Quality Engineers
  • 1 Business Intelligence Expert
  • 7 Front End Software Engineers
  • 16 Back End Software Engineers
  • 3 Full Stack Software Engineers
  • 1 Salesforce Engineer
Tech Stack
  • Javascript
  • Node.js
  • React
  • C#
  • Typescript
  • Java
  • AWS
  • Postgres
  • Jest
  • Cypress
  • Selenium

As Foundation Medicine outgrew their technology core, unosquare oversaw migration from Medical Reporting to MR2, using a nodeJS/Oracle stack and later migrated to Postgres.

unosquare has been involved in the development and launch of 3 groundbreaking genomic cancer profiling products including Foundation One Heme, Liquid Biopsy Assay and FoundationOne Liquid. Our team has developed the UI that interprets genomic case information, managed migration to cloud-based technology, and set up and maintained back end engines behind it all.

Average Time to Fill

14 days
Unosquare Logo Graph

Checkmark Icon

Duration

12+ years
Unosquare Logo Graph

Checkmark Icon

Share

What if your next big breakthrough started here?

Fresh perspectives on modernization. Team-building strategies that work. AI applications you can actually implement. No buzzwords, just insights that move your business forward.

Help us customize your content with the following 2 questions:

Thank you!

We’re excited to have you with us! Keep an eye out for our next update – we can’t wait to share more.